Medpace Holdings Inc (MEDP)
393.28
-12.60
(-3.10%)
USD |
NASDAQ |
May 16, 16:00
393.69
+0.41
(+0.10%)
After-Hours: 20:00
Medpace Holdings Gross Profit (Quarterly): 155.14M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 155.14M |
December 31, 2023 | 136.81M |
September 30, 2023 | 133.19M |
June 30, 2023 | 124.32M |
March 31, 2023 | 130.19M |
December 31, 2022 | 115.73M |
September 30, 2022 | 119.03M |
June 30, 2022 | 99.00M |
March 31, 2022 | 98.68M |
December 31, 2021 | 87.98M |
September 30, 2021 | 87.09M |
June 30, 2021 | 74.65M |
March 31, 2021 | 78.43M |
December 31, 2020 | 82.85M |
September 30, 2020 | 74.16M |
June 30, 2020 | 56.64M |
March 31, 2020 | 65.08M |
December 31, 2019 | 62.70M |
September 30, 2019 | 64.17M |
Date | Value |
---|---|
June 30, 2019 | 63.79M |
March 31, 2019 | 55.04M |
December 31, 2018 | 60.98M |
September 30, 2018 | 55.26M |
June 30, 2018 | 53.47M |
March 31, 2018 | 45.82M |
December 31, 2017 | 43.88M |
September 30, 2017 | 45.54M |
June 30, 2017 | 42.60M |
March 31, 2017 | 42.68M |
December 31, 2016 | 44.30M |
September 30, 2016 | 43.59M |
June 30, 2016 | 43.40M |
March 31, 2016 | 40.82M |
December 31, 2015 | 41.46M |
September 30, 2015 | 39.88M |
June 30, 2015 | 38.15M |
March 31, 2015 | 36.90M |
March 31, 2014 | 31.49M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
56.64M
Minimum
Jun 2020
155.14M
Maximum
Mar 2024
95.48M
Average
87.54M
Median
Gross Profit (Quarterly) Benchmarks
Charles River Laboratories International Inc | 344.84M |
Avid Bioservices Inc | 2.383M |
Iovance Biotherapeutics Inc | -6.546M |
Renovaro Inc | -- |
Candel Therapeutics Inc | -- |